ahlam1399
09-27-2016, 03:15 AM
Cancer patients may be overly optimistic about early drug trial participation
(Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Yz30BahflsA:jZPmEfR2vxw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Yz30BahflsA:jZPmEfR2vxw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Yz30BahflsA
(Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Yz30BahflsA:jZPmEfR2vxw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Yz30BahflsA:jZPmEfR2vxw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Yz30BahflsA:jZPmEfR2vxw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Yz30BahflsA